NOMESIS Suspension

Domperidone 5 mg / 5 ml

COMPOSITIONS :

Nomesis® Suspension 5 mg/5 ml, each 5 ml (a measuring spoon) contains : Domperidone maleatee equivalent to Domperidone 5 mg.

 

DESCRIPTIONS :

Nomesis® contains Domperidone maleate (equivalent to Domperidone) is available in film coated tablet 10 mg and suspension 5 mg/5 ml.

 

INDICATIONS :

Adults :

  • For acute nausea and vomiting. Not recommended for prevention routinely in vomiting after operation.
  • For nausea and vomiting induced by Levodopa and Bromocriptine, Nomesis® should not be use for more than 12 weeks.
  • Treatment of functional dyspepsia symptoms. Not recommended for prolonged therapy.

Children :

  • Not recommended, except for nausea and vomiting in patients on chemotherapy and radiotherapy.

 

DOSAGE AND ADMINISTRATIONS :

Functional dyspepsia :

  • Adults and elderly : 2 – 4 measuring spoons (10 – 20 ml), 3 times daily and 2 – 4 measuring spoons (10 – 20 ml) once more before retiring depending on clinical response. Do not use exceeding 12 weeks.
  • Children : Not recommended.

Nausea and vomiting (include induced by Levodopa and Bromocriptine) :

  • Adults (and elderly) : 2 – 4 measuring spoons (10 – 20 ml), with interval 4 – 8 hours.
  • Children (on chemotherapy and radiotherapy) : 0.2 – 0.4 mg/kgBW daily, with interval 4 – 8 hours.

Nomesis® suspension should be taken 15 – 30 minutes before meals and before retiring.

 

OVERDOSAGE :

  • There has been no experience with overdosage of oral Domperidone.
  • There is no specific antidote to Domperidone, but in the event of overdosage, gastric lavage may be useful.

 

CONTRAINDICATIONS :

  • Patient with known hypersensitivity to Domperidone.
  • Children (except for preventing nausea and vomiting on chemotherapy and radiotherapy).
  • Patient with prolactinoma and pituitary tumor which produce prolactin.

 

WARNINGS AND PRECAUTIONS :

  • Used with caution in pregnant women or nursing mothers.
  • Not recommended for long term treatment.
  • Used with caution in patients with hepatic and renal impairments.

 

PRESENTATIONS :

Nomesis® Suspension 5 mg/5 ml                              Box, 1 bottle @ 60 ml

Reg. No. DKL1102344633A1

 

STORAGE :

STORE BELOW 30ºC, protect from light

 

ON MEDICAL PRESCRIPTION ONLY

 

Manufactured by :

PT. BERNOFARM

Sidoarjo – Indonesia